|
FRONTIERS IN SCIENCE:A series of lectures for donors and friends by
scientists from The Scripps Research Institute on diseases, recent discoveries,
and the application of knowledge to health care.
October 29th, 2009
Frontiers in Science was featuring Dr. Peter Kuhn who presented a lecture:
“Novel Approaches to Monitoring
the Spread of Cancer Cells — Finding the Needle in the Haystack to Develop
Specialized Treatments”
While cancer patients are benefiting substantially from the availability of
more and more treatment choices, new approaches are needed to make treatment
decisions that are applicable to each individual patient.
Metastasis, the major cause of mortality in patients with cancer, is caused
by tumor cells that escape from the primary tumor into the bloodstream and
travel through the circulation to distant sites where they develop into
secondary tumors. The factors involved in circulating tumor cell (CTC) survival
in the blood circulation and eventual metastases are not well understood. CTCs
exist in the peripheral blood of cancer patients in low concentrations, making
their isolation and identification a difficult task. It is like both finding a
needle in a haystack and reading a book in a foreign language.
Scripps Research Associate Professor Peter Kuhn and his fellow biologists,
physicists, and clinicians have developed a reliable way to detect and to
characterize CTCs isolated from the blood of cancer patients, and are currently
involved in multiple ongoing clinical trials. The messages contained in the
cells that they are uncovering could aid physicians in better utilizing current
therapies, as well as developing specialized treatments in the future. For
details on Dr. Kuhn’s work, please visit
http://cancer.scripps.edu.
This text will be replaced
|